Micro Systems Engineering Competitors and Similar CompaniesClear all

Cardiovascular Systems's competitors and similar companies include Cynosure, Nordson MEDICAL and Accuray.

	Cardiovascular Systems Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD).	Cynosure Cynosure is a company that develops and manufactures aesthetic and medical treatment systems.	Nordson MEDICAL Nordson MEDICAL Design and Development is a company that manufactures medical devices and component technologies.	Accuray Accuray is a radiation therapy company that develops, manufactures, sells, and supports radiation treatment solutions.
Founding Date	Founding Date 1989	Founding Date 1991	Founding Date 1968	Founding Date 1990
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare distribution medical devices medtech professional education	Tags Manufacturing & Industrial health & beauty lasers medical devices	Tags Manufacturing & Industrial ecommerce medical devices medtech polymers	Tags Manufacturing & Industrial medical devices medtech oncology therapy
Locations	Locations Saint Paul, US HQ	Locations Westford, US HQ Pymble, AU Hangzhou, CN Suzhou, CN Courbevoie, FR Langen (Hessen), DE Tokyo, JP see more	Locations Minneapolis, US HQ Boyle, IE Galway, IE Katzrin, IL Guaymas, MX Tecate, MX Chattanooga, US see more	Locations Madison, US HQ Chengdu, CN Kowloon, HK Tokyo, JP Morges, CH Santa Clara, US Sunnyvale, US
Employees	Employees 7257% decrease	Employees 8141% decrease	Employees 979	Employees 9874% decrease
Valuation ($)	Valuation ($) 844 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 186.5 m
Financial
Revenue (est.)	Revenue (est.) $236.2m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $446.6m (FY, 2024)
Cost of goods	Cost of goods $63.4m (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods $303.6m (FY, 2024)
Gross profit	Gross profit $172.8m (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit $142.9m (FY, 2024)
Net income	Net income ($36.9m) (FY, 2022)	Net income N/A	Net income N/A	Net income ($15.5m) (FY, 2024)